Product Images Doxazosin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Doxazosin NDC 71610-927 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - 71610 0927 53
Aphena - Aphena
Chemical Structure - doxazosin 01
Table 3 - doxazosin 02
This is a summary of effectiveness data from placebo-controlled trials evaluating the impact of Cardura on maximum flow rate and symptom scores in patients with BPH. The trials involved different dosage titration methods and assessed changes from baseline to endpoint. Cardura showed improvement in maximum flow rate and symptoms compared to placebo, based on AUA questionnaire and Modified Boyarsky Questionnaire results. Study results suggest that Cardura, particularly at higher doses, could be beneficial in managing BPH symptoms.*
Figure 1 - doxazosin 03
This is a comparison table displaying the mean change in total symptom score and mean increase in maximum urinary flow rate from baseline across different durations of treatment in weeks. It includes results for Placebo and Doxazosin, with statistical significance indicated. The text mentions that Doxazosin was titrated up to a maximum of 8 mg.*
Logo - doxazosin 04
This is a description of a product labeled as "GREENSTONE® BRAND" distributed by Greenstone LLC based in Peapack, NJ 07977.*
Logo - doxazosin 04a
This is a description of a pharmaceutical product named Greenstone® Brand, distributed by Greenstone LLC based in Peapack, NJ 07977.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
